The evolution of therapeutic modalities drives the adoption of single-use technologies.
Lonza to Establish Strategic Chinese Biomanufacturing Base
December 10th 2018The company will use GE Healthcare’s off-the-shelf KUBio biologics factory, which is expected to start operations in 2020, to provide development and manufacturing for early- to late-clinical and early-commercial manufacturing stages.
Tech Transfer: Tearing Down the Wall
December 2nd 2018Once described as “throwing processes over the wall,” tech transfer is evolving into close collaboration and communication, as potential problems are considered sooner, and new technology is applied. Joseph Szczesiul, director of technical services for UPM Pharmaceuticals, shares best practices.
Five Additional EU Member States Able to Perform GMP Inspections Equivalent to US Level
November 30th 2018Five additional European Union member states have been confirmed by the US Food and Drug Administration (FDA) as capable of performing good manufacturing practice inspections at a level equivalent to that of the United Sates
International Partnership Aims to Develop Needle-free Vaccines
November 21st 2018The University of South Australia is working to develop needle-free vaccines for Zika, chikingunya, and peanut allergy in a collaboration with Australian biotechnology company Sementis and Enesi Pharma, a United Kingdom-based pharmaceutical company.